Back to search

National and Kapodistrian University of Athens

Μεθοδολογία στη σύνθεση πεπτιδίων. Σύνθεση επιλεγμένων πεπτιδικών τμημάτων πρωτεϊνών. Μελέτη της ανοσογονικότητας τους μετά από σύζευξη με φυσικές μεγαλοπρωτεϊνες ή επιλεγμένους συνθετικούς φορείς

Abstract

dc:description

The proteins are consisted of α-aminoacids having between them an amide bond known as peptide bond. The proteins participate in most of the functions of the human organism, especially in its defence. There are two mechanisms of defence i) the natural defence system, and ii) the immune system which produces the antibodies. The production of antibodies is caused by the antigens. The antibodies have a special affinity with the antigens. This affinity includes only a certain place of the antigen which is called epitope. Proteins can play the role of antigens. Peptides and small proteins can not raise the production of antibodies by themselves but it can be achieved if they are attached to macromolecules. The most common macromolecules are big proteins such as keyhole limpet haimocyanin (KLH), bovine serra albuvine (BSA). In 1988 the dendrimeric peptides were introduced in order to replace the above macromolecules. The dendrimeric peptides are artificial proteins and they found applications in biochemical and biopharmaceutical research. All the dendrimeric peptides share a similar design of branching from a core that gives them different architectures and dendrimeric characteristics. Several variations of branched peptides have been developed which differ only in the design of the core matrix. The core of the most common type of dendrimeric contains two or three levels of branched lysines. The dendrimeric peptides have found applications as immunogens, antigens for diagnostics and inhibitors of cell attachment. Recently a new type of multilysinic peptide introduced. The characteristic of this new molecule is the repetion of the tripeptide (Lys-Aib-Gly)n (n = 2 - 7) which gives a helical shape to the molecule. It allows the antigenic peptides to hold their original active structure, by this way is achieved a higher raise of antibody titers. In this research we compared and tested the anosogenicity of peptide dendrimers consisted of branched lysines and multiple copies of the peptide sequences 830 - 843 of tetanus toxin (T-epitope) and 101 -109 of prothymosin A (B-epitope). We concluded that these branched peptides can not be proposed as alternatives of KLH for raising high antibody titers. The SPPS is a successfully used method for the synthesis of peptides. Even if most of the problems of this method, have been solved there is one more. This problem is the incomplete aminoacylation during the coupling step. It is believed that this problem is caused due to the formation of intramolecular hydrogen bonds between the growing peptides. The problem has two obvious solutions: i) we repeat the coupling step until no unreacted amino group is 162 detected. In this case we increase the cost of the synthesis, ii) we terminate the unreacted amino group with a propere reagent. Our research focused on finding a reagent which can permanently terminate the unreacted amino group but also can make the purification with HPLC easy. We chose to synthesise a peptide whose synthesis is difficult. This peptide was H-(Ala)10-Lys-OH and we built it in four different ways: i) without the use of terminating agent, ii) with the use of acetic anhydride as terminating raegent, hi) with the use of methanesulforic acid as terminating raegent, iv) with the use of 4-phenyl benzoic acid as terminating raegent. By comparing the analytical results (MS and HPLC) of the final product we found out that 4-phenyl benzoic acid makes the purification easy but it does not terminate the unreacted amino groups. In order to increase the ractivity of our reagent we built the product of proline with 4-phenyl benzoic acid. We chose proline because we can built stable halides of this new molecule. Our reagent used as terminating reagent for the above peptide activated as: i) acylfluoride, ii) DIC, DMAP, iii) HOBT, DIC, DMAP. The study of the analytical data indicates us that we achieved our goal. Our tenninating reagent was also used for the synthesis of H-Ala-Arg-(Ala)6-Lys-OH (we wanted to see how the strong activation of the reagent effects in the guanido group), and the peptide 65-74 of ACP. Both peptides have difficulties in their synthesis. The study of the analytical data (MS, HPLC) supported our claim that this reagent can be used in SPPS as terminating reagent.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vavourakis, Nikolaos
  • Βαβουράκης, Νικόλαος

Subjects

dc:subject × 4

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/7211

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vavourakis, Nikolaos; Βαβουράκης, Νικόλαος. Μεθοδολογία στη σύνθεση πεπτιδίων. Σύνθεση επιλεγμένων πεπτιδικών τμημάτων πρωτεϊνών. Μελέτη της ανοσογονικότητας τους μετά από σύζευξη με φυσικές μεγαλοπρωτεϊνες ή επιλεγμένους συνθετικούς φορείς. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/7211